Original Research
Published on 08 Oct 2025
Addition of bevacizumab to gefitinib plus chemotherapy as first-line therapy in EGFR L858R mutate advanced non-small cell lung cancer patients
in Pharmacology of Anti-Cancer Drugs
- 517 views
Original Research
Published on 08 Oct 2025
in Pharmacology of Anti-Cancer Drugs
Core Concept
Published on 08 Oct 2025
in Neuroscience and Psychology
Original Research
Published on 08 Oct 2025
in Digital Learning Innovations
Original Research
Published on 08 Oct 2025
in Work, Employment and Organizations
Opinion
Published on 08 Oct 2025
in Learning and Memory
Original Research
Published on 08 Oct 2025
in Intensive Care Medicine and Anesthesiology
Original Research
Published on 08 Oct 2025
in Psycho-Oncology
Original Research
Published on 08 Oct 2025
in Obstetrics and Gynecological Surgery
Original Research
Published on 08 Oct 2025
in RNA Bioinformatics
Review
Published on 08 Oct 2025
in Infectious Diseases: Pathogenesis and Therapy
Case Report
Published on 08 Oct 2025
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Published on 08 Oct 2025
in Children and Health
Original Research
Published on 08 Oct 2025
in Maternal Health
Original Research
Published on 08 Oct 2025
in Structural Sensing, Control and Asset Management
Study Protocol
Published on 08 Oct 2025
in Personalized Medicine
Case Report
Published on 08 Oct 2025
in Genitourinary Oncology